OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritis
Philip J. Mease, Alice B. Gottlieb, Désirée van der Heijde, et al.
Annals of the Rheumatic Diseases (2017) Vol. 76, Iss. 9, pp. 1550-1558
Open Access | Times Cited: 196

Showing 1-25 of 196 citing articles:

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update
Laure Gossec, Xenofon Baraliakos, Andreas Kerschbaumer, et al.
Annals of the Rheumatic Diseases (2020) Vol. 79, Iss. 6, pp. 700.1-712
Open Access | Times Cited: 834

2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis
Jasvinder A. Singh, Gordon Guyatt, Alexis Ogdie, et al.
Arthritis Care & Research (2018) Vol. 71, Iss. 1, pp. 2-29
Open Access | Times Cited: 438

2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis
Jasvinder A. Singh, Gordon Guyatt, Alexis Ogdie, et al.
Arthritis & Rheumatology (2018) Vol. 71, Iss. 1, pp. 5-32
Open Access | Times Cited: 401

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021
Laura C. Coates, Enrique R. Soriano, Nadia Corp, et al.
Nature Reviews Rheumatology (2022) Vol. 18, Iss. 8, pp. 465-479
Open Access | Times Cited: 363

Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
Cheng Zhou, Xiangqian Li, Chen Wang, et al.
Clinical Reviews in Allergy & Immunology (2021) Vol. 61, Iss. 3, pp. 403-423
Closed Access | Times Cited: 230

Psoriatic arthritis
Oliver FitzGerald, Alexis Ogdie, Vinod Chandran, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 194

Molecular and Cellular Functions of CTLA-4
Samya Van Coillie, Bartosz Wiernicki, Jie Xu
Advances in experimental medicine and biology (2020), pp. 7-32
Closed Access | Times Cited: 182

Pharmacological treatment of psoriatic arthritis: a systematic literature research for the 2019 update of the EULAR recommendations for the management of psoriatic arthritis
Andreas Kerschbaumer, Josef S Smolen, Maxime Dougados, et al.
Annals of the Rheumatic Diseases (2020) Vol. 79, Iss. 6, pp. 778-786
Open Access | Times Cited: 169

Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches
Robert Pollmann, Thomas Schmidt, Rüdiger Eming, et al.
Clinical Reviews in Allergy & Immunology (2018) Vol. 54, Iss. 1, pp. 1-25
Closed Access | Times Cited: 169

Targeted Immunotherapy for Autoimmune Disease
Seung Min Jung, Wan‐Uk Kim
Immune Network (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 110

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update
Laure Gossec, Andreas Kerschbaumer, Ricardo J O Ferreira, et al.
Annals of the Rheumatic Diseases (2024) Vol. 83, Iss. 6, pp. 706-719
Open Access | Times Cited: 83

2022 French Society for Rheumatology (SFR) recommendations on the everyday management of patients with spondyloarthritis, including psoriatic arthritis
Daniel Wendling, Sophie Hecquet, O. Fogel, et al.
Joint Bone Spine (2022) Vol. 89, Iss. 3, pp. 105344-105344
Open Access | Times Cited: 81

Enthesitis: A hallmark of psoriatic arthritis
Gurjit S. Kaeley, Lihi Eder, Sibel Zehra Aydın, et al.
Seminars in Arthritis and Rheumatism (2018) Vol. 48, Iss. 1, pp. 35-43
Open Access | Times Cited: 159

Psoriatic arthritis
Vanessa Ocampo D, Dafna D. Gladman
F1000Research (2019) Vol. 8, pp. 1665-1665
Open Access | Times Cited: 144

Cartilage and Bone Destruction in Arthritis: Pathogenesis and Treatment Strategy: A Literature Review
Daisuke Tateiwa, Hideki Yoshikawa, Takashi Kaito
Cells (2019) Vol. 8, Iss. 8, pp. 818-818
Open Access | Times Cited: 135

Clinical management of psoriatic arthritis
Filip Van den Bosch, Laura C. Coates
The Lancet (2018) Vol. 391, Iss. 10136, pp. 2285-2294
Open Access | Times Cited: 120

Dactylitis: A hallmark of psoriatic arthritis
Gurjit S. Kaeley, Lihi Eder, Sibel Zehra Aydın, et al.
Seminars in Arthritis and Rheumatism (2018) Vol. 48, Iss. 2, pp. 263-273
Open Access | Times Cited: 114

TNF Inhibitor-Induced Psoriasis: Proposed Algorithm for Treatment and Management
Sara J. Li, Lourdes M. Pérez-Chada, Joseph F. Merola
Journal of Psoriasis and Psoriatic Arthritis (2018) Vol. 4, Iss. 2, pp. 70-80
Open Access | Times Cited: 95

Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus biologics
Ying‐Ming Chiu, Der‐Yuan Chen
Expert Review of Clinical Immunology (2019) Vol. 16, Iss. 2, pp. 207-228
Closed Access | Times Cited: 88

Drug repurposing to improve treatment of rheumatic autoimmune inflammatory diseases
Kathryn M. Kingsmore, Amrie C. Grammer, Peter E. Lipsky
Nature Reviews Rheumatology (2019) Vol. 16, Iss. 1, pp. 32-52
Closed Access | Times Cited: 80

Follicular helper T cell profiles predict response to costimulation blockade in type 1 diabetes
Natalie M. Edner, Frank Heuts, Niclas Thomas, et al.
Nature Immunology (2020) Vol. 21, Iss. 10, pp. 1244-1255
Open Access | Times Cited: 76

Efficacy and safety of biologics in psoriatic arthritis: a systematic literature review and network meta-analysis
Adeline Ruyssen‐Witrand, Richard Perry, Clare J. Watkins, et al.
RMD Open (2020) Vol. 6, Iss. 1, pp. e001117-e001117
Open Access | Times Cited: 74

Current Understanding of Cytotoxic T Lymphocyte Antigen-4 (CTLA-4) Signaling in T-Cell Biology and Disease Therapy
Gil‐Ran Kim, Je‐Min Choi
Molecules and Cells (2022) Vol. 45, Iss. 8, pp. 513-521
Open Access | Times Cited: 54

Treatment of autoimmunity: The impact of disease-modifying therapies in multiple sclerosis and comorbid autoimmune disorders
Franz Felix Konen, Nora Möhn, Torsten Witte, et al.
Autoimmunity Reviews (2023) Vol. 22, Iss. 5, pp. 103312-103312
Open Access | Times Cited: 34

Page 1 - Next Page

Scroll to top